Blood filter shows promise for severe psoriasis in early trial
NCT ID NCT06640114
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed pilot study tested whether filtering inflammatory molecules from the blood using a device called Efferon CT can help people with severe psoriasis. Sixty adults with moderate to severe plaque psoriasis received the treatment, which involves circulating blood through a special filter for 2 to 6 hours. Researchers measured changes in skin symptoms and quality of life to see if this approach is safe and effective.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Efferon CT device (blood filter that removes inflammatory molecules)
What this could lead to
If successful, this could offer a new treatment option for severe psoriasis by filtering out inflammatory substances from the blood.
What could go wrong
This is a small pilot study with only 60 participants and no control group, so results may not be conclusive. The procedure involves blood filtering and carries risks like bleeding or infection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
North-Western State Medical University named after I.I. Mechnikov (NWSMU)
Saint Petersburg, Russia
-
North-Western district scientific and clinical center named after L. G. Sokolov Federal Medical and Biological Agency
Saint Petersburg, 194291, Russia